# Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.

> **NCT06481280** · NA · ACTIVE_NOT_RECRUITING · sponsor: **United Pharmaceuticals** · enrollment: 70 (estimated)

## Conditions studied

- Cow's Milk Allergy

## Interventions

- **DIETARY_SUPPLEMENT:** Test Formula
- **DIETARY_SUPPLEMENT:** Placebo Formula

## Key facts

- **NCT ID:** NCT06481280
- **Lead sponsor:** United Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2026-01
- **Final completion:** 2026-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481280, "Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06481280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*